Stock Information
Kalvista Pharmaceuticals Inc (KALV)
Ticker Symbol: KALV
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $813.25 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.9468
Revenue (TTM): $0.28 M
Dividend Yield: N/A%
ROE: -237.53%
Latest News
-
KalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call Transcript
Wed, Mar 25, 2026 2:55 PM
-
Earnings Scheduled For March 25, 2026
Wed, Mar 25, 2026 7:11 AM
-
KalVista Pharma Reported $49.1M In Net Product Revenue For The Eight Months Ended December 31, 2025, Held $300.2M In Cash Balance
Wed, Mar 25, 2026 7:03 AM
-
KalVista Pharma To Present New Interim Data From KONFIDENT-KID Trial Evaluating Sebetralstat In Children Aged 2-11 At 2026 Global Angioedema Leadership Conference
Fri, Mar 20, 2026 7:02 AM
Key Financials
Financial data not available
